Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

AGS-16C3F (Synonyms: AGS-16M8F)

Catalog No. T9901A-963 Copy Product Info
🥰Excellent
AGS-16C3F is an antibody-drug conjugate (ADC) targeting ENPP3 (also known as CD203c). This product consists of a humanized IgG1 monoclonal antibody against ENPP3 conjugated to the microtubule inhibitor monomethyl auristatin F (MMAF) via a non-cleavable linker. AGS-16C3F functions by specifically binding to ENPP3 on the surface of tumor cells, undergoing internalization, and releasing MMAF intracellularly to induce cell cycle arrest and apoptosis. It exhibits potent anti-tumor and anti-proliferative activity in ENPP3-expressing metastatic renal cell carcinoma (mRCC) and systemic mastocytosis.

AGS-16C3F

Copy Product Info
🥰Excellent
Catalog No. T9901A-963
Synonyms AGS-16M8F

AGS-16C3F is an antibody-drug conjugate (ADC) targeting ENPP3 (also known as CD203c). This product consists of a humanized IgG1 monoclonal antibody against ENPP3 conjugated to the microtubule inhibitor monomethyl auristatin F (MMAF) via a non-cleavable linker. AGS-16C3F functions by specifically binding to ENPP3 on the surface of tumor cells, undergoing internalization, and releasing MMAF intracellularly to induce cell cycle arrest and apoptosis. It exhibits potent anti-tumor and anti-proliferative activity in ENPP3-expressing metastatic renal cell carcinoma (mRCC) and systemic mastocytosis.

AGS-16C3F
Pack SizePriceUSA StockGlobal StockQuantity
1 mgInquiryInquiryInquiry
5 mgInquiryInquiryInquiry
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
AGS-16C3F is an antibody-drug conjugate (ADC) targeting ENPP3 (also known as CD203c). This product consists of a humanized IgG1 monoclonal antibody against ENPP3 conjugated to the microtubule inhibitor monomethyl auristatin F (MMAF) via a non-cleavable linker. AGS-16C3F functions by specifically binding to ENPP3 on the surface of tumor cells, undergoing internalization, and releasing MMAF intracellularly to induce cell cycle arrest and apoptosis. It exhibits potent anti-tumor and anti-proliferative activity in ENPP3-expressing metastatic renal cell carcinoma (mRCC) and systemic mastocytosis.
In vitro
AGS-16C3F inhibits proliferation of CD203c-high ROSA cells (96 h IC50: 1.1-2.73 nM), HMC-1.1 (IC50: 109.9 nM), and HMC-1.2 cells (IC50: 146.5 nM). It induces dose-dependent apoptosis (0.5-100 nM, 96-120 h) by disrupting microtubule dynamics [2].
In vivo
In pharmacological studies using NOD-SCID gamma mouse models xenografted with ROSA cells, systemic administration of AGS-16C3F (1 or 4 mg/kg; i.v.; once every 4 days for 4 doses) significantly reduces tumor burden. The treatment leads to a marked decrease in tumor cells within the peripheral blood, bone marrow, and spleen, while significantly prolonging survival without evidence of overt toxicity in complex physiological environments [2].
SynonymsAGS-16M8F
Reactivity
Human
Application
FACS
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Antigen Details
Uniprot ID
TargetENPP3/CD203c
Chemical Properties
Antibody Information
IsotypeIgG1
Storage & Solubility Information
Storagestore at low temperature,keep away from direct sunlight | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy AGS-16C3F | purchase AGS-16C3F | AGS-16C3F cost | order AGS-16C3F | AGS-16C3F in vivo | AGS-16C3F in vitro